rs150923753
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 2P and 12B. PP3_ModerateBP6_Very_StrongBS2
The NM_006514.4(SCN10A):c.1141A>G(p.Ile381Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000323 in 1,614,034 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_006514.4 missense
Scores
Clinical Significance
Conservation
Publications
- sodium channelopathy-related small fiber neuropathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- episodic pain syndrome, familial, 2Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae), Illumina, Ambry Genetics
- Brugada syndromeInheritance: Unknown Classification: LIMITED Submitted by: Genomics England PanelApp
- Brugada syndrome 1Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -10 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SCN10A | NM_006514.4 | c.1141A>G | p.Ile381Val | missense_variant | Exon 10 of 28 | ENST00000449082.3 | NP_006505.4 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SCN10A | ENST00000449082.3 | c.1141A>G | p.Ile381Val | missense_variant | Exon 10 of 28 | 1 | NM_006514.4 | ENSP00000390600.2 | ||
| SCN10A | ENST00000643924.1 | c.1141A>G | p.Ile381Val | missense_variant | Exon 9 of 27 | ENSP00000495595.1 | ||||
| SCN10A | ENST00000655275.1 | c.1168A>G | p.Ile390Val | missense_variant | Exon 10 of 28 | ENSP00000499510.1 |
Frequencies
GnomAD3 genomes AF: 0.000388 AC: 59AN: 152150Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000672 AC: 169AN: 251368 AF XY: 0.000655 show subpopulations
GnomAD4 exome AF: 0.000316 AC: 462AN: 1461884Hom.: 3 Cov.: 32 AF XY: 0.000307 AC XY: 223AN XY: 727244 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000388 AC: 59AN: 152150Hom.: 0 Cov.: 32 AF XY: 0.000377 AC XY: 28AN XY: 74324 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Benign:2
This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Variant summary: SCN10A c.1141A>G (p.Ile381Val) results in a conservative amino acid change in the encoded protein sequence. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change. The variant allele was found at a frequency of 0.00067 in 251368 control chromosomes in the gnomAD database, including 1 homozygotes. The observed variant frequency is approximately 107 fold of the estimated maximal expected allele frequency for a pathogenic variant in SCN10A causing Arrhythmia phenotype (6.3e-06). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. ClinVar contains an entry for this variant (Variation ID: 414634). Based on the evidence outlined above, the variant was classified as likely benign.
not provided Benign:1
SCN10A: PP3, BS1, BS2
Brugada syndrome Benign:1
Cardiovascular phenotype Benign:1
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at